Wells Fargo & Company »

Capricor Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $671k 44k 15.21
2024-06-30 $214k 45k 4.77
2024-03-31 $221k 33k 6.79
2023-12-31 $1.2k 236 4.89
2023-09-30 $642 188 3.42
2023-06-30 $5.6k 1.2k 4.78
2022-12-31 $664 172 3.86
2022-09-30 $999 162 6.17
2022-06-30 $1.0k 163 6.14
2022-03-31 $7.7k 1.1k 6.71
2021-12-31 $0 1.1k 0.00
2021-09-30 $1.0k 140 7.14
2021-06-30 $999 147 6.80
2021-03-31 $1.0k 133 7.52
2020-12-31 $0 133 0.00
2020-09-30 $1.0k 121 8.26
2020-06-30 $0 3.0k 0.00
2020-03-31 $0 23 0.00